Schedule 13G ownership disclosure

CATALYST BIOSCIENCES INC

Security class unavailable · CUSIP: 14888D208

Event date: 2021-01-27

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
2,144,812
Percent of class
6.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000935836-21-000187
Form type
SC 13G/A
Filer
GYRE THERAPEUTICS, INC.
CIK
CIK 1124105
Filed
Feb 19, 2021
Reporting period
Jan 27, 2021
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub